These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of Home Polysomnography Findings, Quality of Sleep, and Fatigue in Inflammatory Bowel Disease: A Case Series. Paixão DL; Poyares D; de Paula MS; Duarte JW; Castelo PM; Ambrogini-Júnior O; Miszputen SJ; Oshima CTF; Chagas JR; Paiotti APR J Clin Sleep Med; 2019 Jan; 15(1):39-45. PubMed ID: 30621826 [TBL] [Abstract][Full Text] [Related]
26. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use. Subramanian S; Asher R; Weston W; Rimmer M; McConville A; Malin A; Jackson R; Collins P; Probert C; Dibb M; Rhodes JM Inflamm Bowel Dis; 2016 Aug; 22(8):1902-7. PubMed ID: 27243590 [TBL] [Abstract][Full Text] [Related]
27. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing. Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482 [TBL] [Abstract][Full Text] [Related]
28. A comparative study of the nature and magnitude of problems sleeping in inflammatory bowel disease (IBD) compared to healthy controls. Scott AJ; Flowers O; Rowse G Psychol Health Med; 2020 Sep; 25(8):958-968. PubMed ID: 31899953 [TBL] [Abstract][Full Text] [Related]
29. Exercise leads to better sleep in children with inflammatory bowel disease. Trivić Mažuranić I; Sila S; Mišak Z; Kolaček S; Hojsak I Pediatr Int; 2024; 66(1):e15788. PubMed ID: 39076057 [TBL] [Abstract][Full Text] [Related]
30. Poor Sleep Quality in Crohn's Disease Is Associated With Disease Activity and Risk for Hospitalization or Surgery. Sofia MA; Lipowska AM; Zmeter N; Perez E; Kavitt R; Rubin DT Inflamm Bowel Dis; 2020 Jul; 26(8):1251-1259. PubMed ID: 31820780 [TBL] [Abstract][Full Text] [Related]
31. Self-reported sleep disturbance in Crohn's disease is not confirmed by objective sleep measures. Iskandar HN; Linan EE; Patel A; Moore R; Lasanajak Y; Gyawali CP; Sayuk GS; Ciorba MA Sci Rep; 2020 Feb; 10(1):1980. PubMed ID: 32029832 [TBL] [Abstract][Full Text] [Related]
32. Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study. Vegni E; Gilardi D; Bonovas S; Corrò BE; Menichetti J; Leone D; Mariangela A; Furfaro F; Danese S; Fiorino G J Crohns Colitis; 2019 Mar; 13(4):417-423. PubMed ID: 30517669 [TBL] [Abstract][Full Text] [Related]
33. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108 [TBL] [Abstract][Full Text] [Related]
34. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983 [TBL] [Abstract][Full Text] [Related]
35. Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Ng SC; Zeng Z; Niewiadomski O; Tang W; Bell S; Kamm MA; Hu P; de Silva HJ; Niriella MA; Udara WS; Ong D; Ling KL; Ooi CJ; Hilmi I; Lee Goh K; Ouyang Q; Wang YF; Wu K; Wang X; Pisespongsa P; Manatsathit S; Aniwan S; Limsrivilai J; Gunawan J; Simadibrata M; Abdullah M; Tsang SW; Lo FH; Hui AJ; Chow CM; Yu HH; Li MF; Ng KK; Ching JY; Chan V; Wu JC; Chan FK; Chen M; Sung JJ; Gastroenterology; 2016 Jan; 150(1):86-95.e3; quiz e13-4. PubMed ID: 26385074 [TBL] [Abstract][Full Text] [Related]
37. Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases. Roblin X; Marotte H; Rinaudo M; Del Tedesco E; Moreau A; Phelip JM; Genin C; Peyrin-Biroulet L; Paul S Clin Gastroenterol Hepatol; 2014 Jan; 12(1):80-84.e2. PubMed ID: 23891927 [TBL] [Abstract][Full Text] [Related]
38. Sleep Disturbance in Inflammatory Bowel Disease Is Associated with Disease Activity and Adverse Outcome. Leal T; Gonçalves M; Antunes P; Costa D; Mendes S; Soares JB; Rebelo A; Gonçalves B; Arroja B; Gonçalves R Dig Dis; 2021; 39(5):496-501. PubMed ID: 33588416 [TBL] [Abstract][Full Text] [Related]
39. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease]. Ciećko-Michalska I; Fedak D; Mach T Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350 [TBL] [Abstract][Full Text] [Related]
40. Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease. Bar-Gil Shitrit A; Chen-Shuali C; Adar T; Koslowsky B; Shteingart S; Paz K; Grisaru-Granovsky S; Goldin E; Epstein Shochet G; Shitrit D Dig Dis Sci; 2018 Nov; 63(11):2992-2997. PubMed ID: 30027514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]